Retigabine

CAS No. 150812-12-7

Retigabine( D 23129 | GKE-841 | GW 582892X | WAY-143841 )

Catalog No. M12105 CAS No. 150812-12-7

Retigabine (Ezogabine; D23129) is a Kv7.2-7.5 (KCNQ2-5) neuronal potassium channel opener witrh anticonvulsant activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Retigabine
  • Note
    Research use only, not for human use.
  • Brief Description
    Retigabine (Ezogabine; D23129) is a Kv7.2-7.5 (KCNQ2-5) neuronal potassium channel opener witrh anticonvulsant activity.
  • Description
    Retigabine (Ezogabine; D23129) is a Kv7.2-7.5 (KCNQ2-5) neuronal potassium channel opener witrh anticonvulsant activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    D 23129 | GKE-841 | GW 582892X | WAY-143841
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Potassium Channel
  • Recptor
    KCNQ2/Q3 channels| KCNQ3/5| KCQN4
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    150812-12-7
  • Formula Weight
    303.33
  • Molecular Formula
    C16H18FN3O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    CCOC(=O)NC1=C(N)C=C(NCC2=CC=C(F)C=C2)C=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.M.J. Brodie, et al. Neurology November 16, 2010 vol. 75 no. 20 1817-1824 .
molnova catalog
related products
  • BSH-IN-1

    BSH-IN-1 is a potent, covalent inhibitor of gut bacterial recombinant bile salt hydrolases (BSHs; IC50s: 108 nM for B. longum BSH and 427 nM for B. theta BSH).

  • Guangxitoxin 1E

    Guangxitoxin 1E acts as a gating modifier since it shifts the voltage-dependence of Kv2.1 K+ currents towards depolarized potentials.

  • Kv2-IN-A1

    Kv2-IN-A1 is an inhibitor of Kv2.1 and Kv2.2.